pkg actually acquired these two companies? puzzle pieces fit nicely
said Almir Garibovic, CEO of PKG. “As PKG is in the final stages of joining Cerebain Biotech Corporation, we are very eager to continue investing in promising start-up companies. With the addition of these highly sophisticated products for Allevion Therapeutics and Pressao Medical, we will ensure that our vision and long-term strategy are aligned with Cerebain Biotech [color=red][/color]Corporation. Once the merger is complete, we intend to add several more start-up companies to our investment portfolio in the near future.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.